Global Radiopharmaceutical Therapy Production, Demand and Key Producers, 2022-2028
This report studies the global Radiopharmaceutical Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Radiopharmaceutical Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radiopharmaceutical Therapy that contribute to its increasing demand across many markets.
The global Radiopharmaceutical Therapy market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Radiopharmaceutical Therapy total market, 2017-2028, (USD Million)
Global Radiopharmaceutical Therapy total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Radiopharmaceutical Therapy total market, key domestic companies and share, (USD Million)
Global Radiopharmaceutical Therapy revenue by player and market share 2017-2022, (USD Million)
Global Radiopharmaceutical Therapy total market by Type, CAGR, 2017-2028, (USD Million)
Global Radiopharmaceutical Therapy total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Radiopharmaceutical Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radiopharmaceutical Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Radiopharmaceutical Therapy Market, By Region:
1. How big is the global Radiopharmaceutical Therapy market?
2. What is the demand of the global Radiopharmaceutical Therapy market?
3. What is the year over year growth of the global Radiopharmaceutical Therapy market?
4. What is the total value of the global Radiopharmaceutical Therapy market?
5. Who are the major players in the global Radiopharmaceutical Therapy market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Radiopharmaceutical Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radiopharmaceutical Therapy that contribute to its increasing demand across many markets.
The global Radiopharmaceutical Therapy market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Radiopharmaceutical Therapy total market, 2017-2028, (USD Million)
Global Radiopharmaceutical Therapy total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Radiopharmaceutical Therapy total market, key domestic companies and share, (USD Million)
Global Radiopharmaceutical Therapy revenue by player and market share 2017-2022, (USD Million)
Global Radiopharmaceutical Therapy total market by Type, CAGR, 2017-2028, (USD Million)
Global Radiopharmaceutical Therapy total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Radiopharmaceutical Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radiopharmaceutical Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Radiopharmaceutical Therapy Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Actinium-225
- Lutetium-177
- Radium-223
- Holmium-166
- Other
- Oncology
- Cardiology
- Other
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
- Navidea
1. How big is the global Radiopharmaceutical Therapy market?
2. What is the demand of the global Radiopharmaceutical Therapy market?
3. What is the year over year growth of the global Radiopharmaceutical Therapy market?
4. What is the total value of the global Radiopharmaceutical Therapy market?
5. Who are the major players in the global Radiopharmaceutical Therapy market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Radiopharmaceutical Therapy Introduction
1.2 World Radiopharmaceutical Therapy Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Radiopharmaceutical Therapy Total Market by Region
1.3.1 World Radiopharmaceutical Therapy Market Size by Region (2017-2028)
1.3.2 United States Radiopharmaceutical Therapy Market Size (2017-2028)
1.3.3 China Radiopharmaceutical Therapy Market Size (2017-2028)
1.3.4 Europe Radiopharmaceutical Therapy Market Size (2017-2028)
1.3.5 Japan Radiopharmaceutical Therapy Market Size (2017-2028)
1.3.6 South Korea Radiopharmaceutical Therapy Market Size (2017-2028)
1.3.7 ASEAN Radiopharmaceutical Therapy Market Size (2017-2028)
1.3.8 India Radiopharmaceutical Therapy Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Radiopharmaceutical Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Radiopharmaceutical Therapy Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD RADIOPHARMACEUTICAL THERAPY COMPANIES COMPETITIVE ANALYSIS
2.1 World Radiopharmaceutical Therapy Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Radiopharmaceutical Therapy Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Radiopharmaceutical Therapy in 2021
2.2.3 Global Concentration Ratios (CR8) for Radiopharmaceutical Therapy in 2021
2.3 Radiopharmaceutical Therapy Company Evaluation Quadrant
2.4 Radiopharmaceutical Therapy Market: Overall Company Footprint Analysis
2.4.1 Radiopharmaceutical Therapy Market: Region Footprint
2.4.2 Radiopharmaceutical Therapy Market: Company Product Type Footprint
2.4.3 Radiopharmaceutical Therapy Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Radiopharmaceutical Therapy Market Comparison
3.1.1 United States VS China: Radiopharmaceutical Therapy Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Radiopharmaceutical Therapy Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Radiopharmaceutical Therapy Major Players and Market Share, 2017-2022
3.2.1 Major Players of Radiopharmaceutical Therapy in United States, Headquarters (States, Country)
3.2.2 United States Radiopharmaceutical Therapy Revenue by Domestic Player, (2017-2022)
3.3 China Radiopharmaceutical Therapy Major Players and Market Share, 2017-2022
3.3.1 Major Players of Radiopharmaceutical Therapy in China, Headquarters (Province, Country)
3.3.2 China Radiopharmaceutical Therapy Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Radiopharmaceutical Therapy Major Players and Market Share, 2017-2022
3.4.1 Major Players of Radiopharmaceutical Therapy in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Radiopharmaceutical Therapy Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Radiopharmaceutical Therapy Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Actinium-225
4.2.2 Lutetium-177
4.2.3 Radium-223
4.2.4 Holmium-166
4.2.5 Other
4.3 Market Segment by Type
4.3.1 World Radiopharmaceutical Therapy Market Size by Type (2017-2022)
4.3.2 World Radiopharmaceutical Therapy Market Size by Type (2023-2028)
4.3.3 World Radiopharmaceutical Therapy Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Radiopharmaceutical Therapy Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Oncology
5.2.2 Cardiology
5.2.3 Other
5.3 Market Segment by Application
5.3.1 World Radiopharmaceutical Therapy Market Size by Application (2017-2022)
5.3.2 World Radiopharmaceutical Therapy Market Size by Application (2023-2028)
5.3.3 World Radiopharmaceutical Therapy Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Bracco Imaging
6.1.1 Bracco Imaging Details
6.1.2 Bracco Imaging Major Business
6.1.3 Bracco Imaging Radiopharmaceutical Therapy Product and Services
6.1.4 Bracco Imaging Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Bracco Imaging Recent Developments/Updates
6.1.6 Bracco Imaging Competitive Strengths & Weaknesses
6.2 Bayer
6.2.1 Bayer Details
6.2.2 Bayer Major Business
6.2.3 Bayer Radiopharmaceutical Therapy Product and Services
6.2.4 Bayer Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Bayer Recent Developments/Updates
6.2.6 Bayer Competitive Strengths & Weaknesses
6.3 Mallinckrodt
6.3.1 Mallinckrodt Details
6.3.2 Mallinckrodt Major Business
6.3.3 Mallinckrodt Radiopharmaceutical Therapy Product and Services
6.3.4 Mallinckrodt Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Mallinckrodt Recent Developments/Updates
6.3.6 Mallinckrodt Competitive Strengths & Weaknesses
6.4 Nordion
6.4.1 Nordion Details
6.4.2 Nordion Major Business
6.4.3 Nordion Radiopharmaceutical Therapy Product and Services
6.4.4 Nordion Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Nordion Recent Developments/Updates
6.4.6 Nordion Competitive Strengths & Weaknesses
6.5 Triad Isotopes
6.5.1 Triad Isotopes Details
6.5.2 Triad Isotopes Major Business
6.5.3 Triad Isotopes Radiopharmaceutical Therapy Product and Services
6.5.4 Triad Isotopes Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Triad Isotopes Recent Developments/Updates
6.5.6 Triad Isotopes Competitive Strengths & Weaknesses
6.6 Lantheus
6.6.1 Lantheus Details
6.6.2 Lantheus Major Business
6.6.3 Lantheus Radiopharmaceutical Therapy Product and Services
6.6.4 Lantheus Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Lantheus Recent Developments/Updates
6.6.6 Lantheus Competitive Strengths & Weaknesses
6.7 IBA Group
6.7.1 IBA Group Details
6.7.2 IBA Group Major Business
6.7.3 IBA Group Radiopharmaceutical Therapy Product and Services
6.7.4 IBA Group Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 IBA Group Recent Developments/Updates
6.7.6 IBA Group Competitive Strengths & Weaknesses
6.8 GE Healthcare
6.8.1 GE Healthcare Details
6.8.2 GE Healthcare Major Business
6.8.3 GE Healthcare Radiopharmaceutical Therapy Product and Services
6.8.4 GE Healthcare Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 GE Healthcare Recent Developments/Updates
6.8.6 GE Healthcare Competitive Strengths & Weaknesses
6.9 China Isotope & Radiation
6.9.1 China Isotope & Radiation Details
6.9.2 China Isotope & Radiation Major Business
6.9.3 China Isotope & Radiation Radiopharmaceutical Therapy Product and Services
6.9.4 China Isotope & Radiation Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 China Isotope & Radiation Recent Developments/Updates
6.9.6 China Isotope & Radiation Competitive Strengths & Weaknesses
6.10 Jubilant Pharma
6.10.1 Jubilant Pharma Details
6.10.2 Jubilant Pharma Major Business
6.10.3 Jubilant Pharma Radiopharmaceutical Therapy Product and Services
6.10.4 Jubilant Pharma Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Jubilant Pharma Recent Developments/Updates
6.10.6 Jubilant Pharma Competitive Strengths & Weaknesses
6.11 Eli Lilly
6.11.1 Eli Lilly Details
6.11.2 Eli Lilly Major Business
6.11.3 Eli Lilly Radiopharmaceutical Therapy Product and Services
6.11.4 Eli Lilly Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Eli Lilly Recent Developments/Updates
6.11.6 Eli Lilly Competitive Strengths & Weaknesses
6.12 Advanced Accelerator Applications
6.12.1 Advanced Accelerator Applications Details
6.12.2 Advanced Accelerator Applications Major Business
6.12.3 Advanced Accelerator Applications Radiopharmaceutical Therapy Product and Services
6.12.4 Advanced Accelerator Applications Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Advanced Accelerator Applications Recent Developments/Updates
6.12.6 Advanced Accelerator Applications Competitive Strengths & Weaknesses
6.13 SIEMENS
6.13.1 SIEMENS Details
6.13.2 SIEMENS Major Business
6.13.3 SIEMENS Radiopharmaceutical Therapy Product and Services
6.13.4 SIEMENS Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 SIEMENS Recent Developments/Updates
6.13.6 SIEMENS Competitive Strengths & Weaknesses
6.14 Dongcheng
6.14.1 Dongcheng Details
6.14.2 Dongcheng Major Business
6.14.3 Dongcheng Radiopharmaceutical Therapy Product and Services
6.14.4 Dongcheng Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Dongcheng Recent Developments/Updates
6.14.6 Dongcheng Competitive Strengths & Weaknesses
6.15 Navidea
6.15.1 Navidea Details
6.15.2 Navidea Major Business
6.15.3 Navidea Radiopharmaceutical Therapy Product and Services
6.15.4 Navidea Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Navidea Recent Developments/Updates
6.15.6 Navidea Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Radiopharmaceutical Therapy and Key Manufacturers
7.2 Radiopharmaceutical Therapy Manufacturing Costs
7.3 Radiopharmaceutical Therapy Production Process
7.4 Radiopharmaceutical Therapy Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Radiopharmaceutical Therapy Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Radiopharmaceutical Therapy Typical Distributors
8.3 Radiopharmaceutical Therapy Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Radiopharmaceutical Therapy Introduction
1.2 World Radiopharmaceutical Therapy Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Radiopharmaceutical Therapy Total Market by Region
1.3.1 World Radiopharmaceutical Therapy Market Size by Region (2017-2028)
1.3.2 United States Radiopharmaceutical Therapy Market Size (2017-2028)
1.3.3 China Radiopharmaceutical Therapy Market Size (2017-2028)
1.3.4 Europe Radiopharmaceutical Therapy Market Size (2017-2028)
1.3.5 Japan Radiopharmaceutical Therapy Market Size (2017-2028)
1.3.6 South Korea Radiopharmaceutical Therapy Market Size (2017-2028)
1.3.7 ASEAN Radiopharmaceutical Therapy Market Size (2017-2028)
1.3.8 India Radiopharmaceutical Therapy Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Radiopharmaceutical Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Radiopharmaceutical Therapy Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD RADIOPHARMACEUTICAL THERAPY COMPANIES COMPETITIVE ANALYSIS
2.1 World Radiopharmaceutical Therapy Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Radiopharmaceutical Therapy Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Radiopharmaceutical Therapy in 2021
2.2.3 Global Concentration Ratios (CR8) for Radiopharmaceutical Therapy in 2021
2.3 Radiopharmaceutical Therapy Company Evaluation Quadrant
2.4 Radiopharmaceutical Therapy Market: Overall Company Footprint Analysis
2.4.1 Radiopharmaceutical Therapy Market: Region Footprint
2.4.2 Radiopharmaceutical Therapy Market: Company Product Type Footprint
2.4.3 Radiopharmaceutical Therapy Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Radiopharmaceutical Therapy Market Comparison
3.1.1 United States VS China: Radiopharmaceutical Therapy Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Radiopharmaceutical Therapy Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Radiopharmaceutical Therapy Major Players and Market Share, 2017-2022
3.2.1 Major Players of Radiopharmaceutical Therapy in United States, Headquarters (States, Country)
3.2.2 United States Radiopharmaceutical Therapy Revenue by Domestic Player, (2017-2022)
3.3 China Radiopharmaceutical Therapy Major Players and Market Share, 2017-2022
3.3.1 Major Players of Radiopharmaceutical Therapy in China, Headquarters (Province, Country)
3.3.2 China Radiopharmaceutical Therapy Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Radiopharmaceutical Therapy Major Players and Market Share, 2017-2022
3.4.1 Major Players of Radiopharmaceutical Therapy in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Radiopharmaceutical Therapy Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Radiopharmaceutical Therapy Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Actinium-225
4.2.2 Lutetium-177
4.2.3 Radium-223
4.2.4 Holmium-166
4.2.5 Other
4.3 Market Segment by Type
4.3.1 World Radiopharmaceutical Therapy Market Size by Type (2017-2022)
4.3.2 World Radiopharmaceutical Therapy Market Size by Type (2023-2028)
4.3.3 World Radiopharmaceutical Therapy Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Radiopharmaceutical Therapy Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Oncology
5.2.2 Cardiology
5.2.3 Other
5.3 Market Segment by Application
5.3.1 World Radiopharmaceutical Therapy Market Size by Application (2017-2022)
5.3.2 World Radiopharmaceutical Therapy Market Size by Application (2023-2028)
5.3.3 World Radiopharmaceutical Therapy Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Bracco Imaging
6.1.1 Bracco Imaging Details
6.1.2 Bracco Imaging Major Business
6.1.3 Bracco Imaging Radiopharmaceutical Therapy Product and Services
6.1.4 Bracco Imaging Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Bracco Imaging Recent Developments/Updates
6.1.6 Bracco Imaging Competitive Strengths & Weaknesses
6.2 Bayer
6.2.1 Bayer Details
6.2.2 Bayer Major Business
6.2.3 Bayer Radiopharmaceutical Therapy Product and Services
6.2.4 Bayer Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Bayer Recent Developments/Updates
6.2.6 Bayer Competitive Strengths & Weaknesses
6.3 Mallinckrodt
6.3.1 Mallinckrodt Details
6.3.2 Mallinckrodt Major Business
6.3.3 Mallinckrodt Radiopharmaceutical Therapy Product and Services
6.3.4 Mallinckrodt Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Mallinckrodt Recent Developments/Updates
6.3.6 Mallinckrodt Competitive Strengths & Weaknesses
6.4 Nordion
6.4.1 Nordion Details
6.4.2 Nordion Major Business
6.4.3 Nordion Radiopharmaceutical Therapy Product and Services
6.4.4 Nordion Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Nordion Recent Developments/Updates
6.4.6 Nordion Competitive Strengths & Weaknesses
6.5 Triad Isotopes
6.5.1 Triad Isotopes Details
6.5.2 Triad Isotopes Major Business
6.5.3 Triad Isotopes Radiopharmaceutical Therapy Product and Services
6.5.4 Triad Isotopes Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Triad Isotopes Recent Developments/Updates
6.5.6 Triad Isotopes Competitive Strengths & Weaknesses
6.6 Lantheus
6.6.1 Lantheus Details
6.6.2 Lantheus Major Business
6.6.3 Lantheus Radiopharmaceutical Therapy Product and Services
6.6.4 Lantheus Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Lantheus Recent Developments/Updates
6.6.6 Lantheus Competitive Strengths & Weaknesses
6.7 IBA Group
6.7.1 IBA Group Details
6.7.2 IBA Group Major Business
6.7.3 IBA Group Radiopharmaceutical Therapy Product and Services
6.7.4 IBA Group Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 IBA Group Recent Developments/Updates
6.7.6 IBA Group Competitive Strengths & Weaknesses
6.8 GE Healthcare
6.8.1 GE Healthcare Details
6.8.2 GE Healthcare Major Business
6.8.3 GE Healthcare Radiopharmaceutical Therapy Product and Services
6.8.4 GE Healthcare Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 GE Healthcare Recent Developments/Updates
6.8.6 GE Healthcare Competitive Strengths & Weaknesses
6.9 China Isotope & Radiation
6.9.1 China Isotope & Radiation Details
6.9.2 China Isotope & Radiation Major Business
6.9.3 China Isotope & Radiation Radiopharmaceutical Therapy Product and Services
6.9.4 China Isotope & Radiation Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 China Isotope & Radiation Recent Developments/Updates
6.9.6 China Isotope & Radiation Competitive Strengths & Weaknesses
6.10 Jubilant Pharma
6.10.1 Jubilant Pharma Details
6.10.2 Jubilant Pharma Major Business
6.10.3 Jubilant Pharma Radiopharmaceutical Therapy Product and Services
6.10.4 Jubilant Pharma Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Jubilant Pharma Recent Developments/Updates
6.10.6 Jubilant Pharma Competitive Strengths & Weaknesses
6.11 Eli Lilly
6.11.1 Eli Lilly Details
6.11.2 Eli Lilly Major Business
6.11.3 Eli Lilly Radiopharmaceutical Therapy Product and Services
6.11.4 Eli Lilly Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Eli Lilly Recent Developments/Updates
6.11.6 Eli Lilly Competitive Strengths & Weaknesses
6.12 Advanced Accelerator Applications
6.12.1 Advanced Accelerator Applications Details
6.12.2 Advanced Accelerator Applications Major Business
6.12.3 Advanced Accelerator Applications Radiopharmaceutical Therapy Product and Services
6.12.4 Advanced Accelerator Applications Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Advanced Accelerator Applications Recent Developments/Updates
6.12.6 Advanced Accelerator Applications Competitive Strengths & Weaknesses
6.13 SIEMENS
6.13.1 SIEMENS Details
6.13.2 SIEMENS Major Business
6.13.3 SIEMENS Radiopharmaceutical Therapy Product and Services
6.13.4 SIEMENS Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 SIEMENS Recent Developments/Updates
6.13.6 SIEMENS Competitive Strengths & Weaknesses
6.14 Dongcheng
6.14.1 Dongcheng Details
6.14.2 Dongcheng Major Business
6.14.3 Dongcheng Radiopharmaceutical Therapy Product and Services
6.14.4 Dongcheng Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Dongcheng Recent Developments/Updates
6.14.6 Dongcheng Competitive Strengths & Weaknesses
6.15 Navidea
6.15.1 Navidea Details
6.15.2 Navidea Major Business
6.15.3 Navidea Radiopharmaceutical Therapy Product and Services
6.15.4 Navidea Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Navidea Recent Developments/Updates
6.15.6 Navidea Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Radiopharmaceutical Therapy and Key Manufacturers
7.2 Radiopharmaceutical Therapy Manufacturing Costs
7.3 Radiopharmaceutical Therapy Production Process
7.4 Radiopharmaceutical Therapy Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Radiopharmaceutical Therapy Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Radiopharmaceutical Therapy Typical Distributors
8.3 Radiopharmaceutical Therapy Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Radiopharmaceutical Therapy Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Radiopharmaceutical Therapy Market Size by Region (2017-2022) & (USD Million)
Table 3. World Radiopharmaceutical Therapy Market Size by Region (2023-2028) & (USD Million)
Table 4. World Radiopharmaceutical Therapy Market Size Market Share by Region (2017-2022)
Table 5. World Radiopharmaceutical Therapy Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Radiopharmaceutical Therapy Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Radiopharmaceutical Therapy Players in 2021
Table 9. World Radiopharmaceutical Therapy Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Radiopharmaceutical Therapy Company Evaluation Quadrant
Table 11. Head Office of Key Radiopharmaceutical Therapy Player
Table 12. Radiopharmaceutical Therapy Market: Company Product Type Footprint
Table 13. Radiopharmaceutical Therapy Market: Company Product Application Footprint
Table 14. Radiopharmaceutical Therapy Mergers & Acquisitions Activity
Table 15. United States VS China Radiopharmaceutical Therapy Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Radiopharmaceutical Therapy in United States, Headquarters (States, Country)
Table 17. United States Radiopharmaceutical Therapy Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Radiopharmaceutical Therapy Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Radiopharmaceutical Therapy in China, Company Headquarters (Province, Country)
Table 20. China Radiopharmaceutical Therapy Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Radiopharmaceutical Therapy Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Radiopharmaceutical Therapy in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Radiopharmaceutical Therapy Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Radiopharmaceutical Therapy Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Radiopharmaceutical Therapy Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Radiopharmaceutical Therapy Revenue by Type (2017-2022) & (USD Million)
Table 27. World Radiopharmaceutical Therapy Revenue by Type (2023-2028) & (USD Million)
Table 28. World Radiopharmaceutical Therapy Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Radiopharmaceutical Therapy Revenue by Application (2017-2022) & (USD Million)
Table 30. World Radiopharmaceutical Therapy Revenue by Application (2023-2028) & (USD Million)
Table 31. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 32. Bracco Imaging Major Business
Table 33. Bracco Imaging Radiopharmaceutical Therapy Product and Services
Table 34. Bracco Imaging Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Bracco Imaging Recent Developments/Updates
Table 36. Bracco Imaging Competitive Strengths & Weaknesses
Table 37. Bayer Basic Information, Manufacturing Base and Competitors
Table 38. Bayer Major Business
Table 39. Bayer Radiopharmaceutical Therapy Product and Services
Table 40. Bayer Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Bayer Recent Developments/Updates
Table 42. Bayer Competitive Strengths & Weaknesses
Table 43. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 44. Mallinckrodt Major Business
Table 45. Mallinckrodt Radiopharmaceutical Therapy Product and Services
Table 46. Mallinckrodt Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Mallinckrodt Recent Developments/Updates
Table 48. Mallinckrodt Competitive Strengths & Weaknesses
Table 49. Nordion Basic Information, Manufacturing Base and Competitors
Table 50. Nordion Major Business
Table 51. Nordion Radiopharmaceutical Therapy Product and Services
Table 52. Nordion Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Nordion Recent Developments/Updates
Table 54. Nordion Competitive Strengths & Weaknesses
Table 55. Triad Isotopes Basic Information, Manufacturing Base and Competitors
Table 56. Triad Isotopes Major Business
Table 57. Triad Isotopes Radiopharmaceutical Therapy Product and Services
Table 58. Triad Isotopes Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Triad Isotopes Recent Developments/Updates
Table 60. Triad Isotopes Competitive Strengths & Weaknesses
Table 61. Lantheus Basic Information, Manufacturing Base and Competitors
Table 62. Lantheus Major Business
Table 63. Lantheus Radiopharmaceutical Therapy Product and Services
Table 64. Lantheus Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Lantheus Recent Developments/Updates
Table 66. Lantheus Competitive Strengths & Weaknesses
Table 67. IBA Group Basic Information, Manufacturing Base and Competitors
Table 68. IBA Group Major Business
Table 69. IBA Group Radiopharmaceutical Therapy Product and Services
Table 70. IBA Group Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. IBA Group Recent Developments/Updates
Table 72. IBA Group Competitive Strengths & Weaknesses
Table 73. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 74. GE Healthcare Major Business
Table 75. GE Healthcare Radiopharmaceutical Therapy Product and Services
Table 76. GE Healthcare Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. GE Healthcare Recent Developments/Updates
Table 78. GE Healthcare Competitive Strengths & Weaknesses
Table 79. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 80. China Isotope & Radiation Major Business
Table 81. China Isotope & Radiation Radiopharmaceutical Therapy Product and Services
Table 82. China Isotope & Radiation Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. China Isotope & Radiation Recent Developments/Updates
Table 84. China Isotope & Radiation Competitive Strengths & Weaknesses
Table 85. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Jubilant Pharma Major Business
Table 87. Jubilant Pharma Radiopharmaceutical Therapy Product and Services
Table 88. Jubilant Pharma Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Jubilant Pharma Recent Developments/Updates
Table 90. Jubilant Pharma Competitive Strengths & Weaknesses
Table 91. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 92. Eli Lilly Major Business
Table 93. Eli Lilly Radiopharmaceutical Therapy Product and Services
Table 94. Eli Lilly Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Eli Lilly Recent Developments/Updates
Table 96. Eli Lilly Competitive Strengths & Weaknesses
Table 97. Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table 98. Advanced Accelerator Applications Major Business
Table 99. Advanced Accelerator Applications Radiopharmaceutical Therapy Product and Services
Table 100. Advanced Accelerator Applications Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Advanced Accelerator Applications Recent Developments/Updates
Table 102. Advanced Accelerator Applications Competitive Strengths & Weaknesses
Table 103. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 104. SIEMENS Major Business
Table 105. SIEMENS Radiopharmaceutical Therapy Product and Services
Table 106. SIEMENS Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. SIEMENS Recent Developments/Updates
Table 108. SIEMENS Competitive Strengths & Weaknesses
Table 109. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 110. Dongcheng Major Business
Table 111. Dongcheng Radiopharmaceutical Therapy Product and Services
Table 112. Dongcheng Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Dongcheng Recent Developments/Updates
Table 114. Navidea Basic Information, Manufacturing Base and Competitors
Table 115. Navidea Major Business
Table 116. Navidea Radiopharmaceutical Therapy Product and Services
Table 117. Navidea Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 118. Radiopharmaceutical Therapy Raw Material
Table 119. Key Manufacturers of Radiopharmaceutical Therapy Raw Materials
Table 120. Radiopharmaceutical Therapy Typical Distributors
Table 121. Radiopharmaceutical Therapy Typical Customers
Table 1. World Radiopharmaceutical Therapy Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Radiopharmaceutical Therapy Market Size by Region (2017-2022) & (USD Million)
Table 3. World Radiopharmaceutical Therapy Market Size by Region (2023-2028) & (USD Million)
Table 4. World Radiopharmaceutical Therapy Market Size Market Share by Region (2017-2022)
Table 5. World Radiopharmaceutical Therapy Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Radiopharmaceutical Therapy Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Radiopharmaceutical Therapy Players in 2021
Table 9. World Radiopharmaceutical Therapy Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Radiopharmaceutical Therapy Company Evaluation Quadrant
Table 11. Head Office of Key Radiopharmaceutical Therapy Player
Table 12. Radiopharmaceutical Therapy Market: Company Product Type Footprint
Table 13. Radiopharmaceutical Therapy Market: Company Product Application Footprint
Table 14. Radiopharmaceutical Therapy Mergers & Acquisitions Activity
Table 15. United States VS China Radiopharmaceutical Therapy Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Radiopharmaceutical Therapy in United States, Headquarters (States, Country)
Table 17. United States Radiopharmaceutical Therapy Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Radiopharmaceutical Therapy Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Radiopharmaceutical Therapy in China, Company Headquarters (Province, Country)
Table 20. China Radiopharmaceutical Therapy Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Radiopharmaceutical Therapy Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Radiopharmaceutical Therapy in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Radiopharmaceutical Therapy Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Radiopharmaceutical Therapy Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Radiopharmaceutical Therapy Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Radiopharmaceutical Therapy Revenue by Type (2017-2022) & (USD Million)
Table 27. World Radiopharmaceutical Therapy Revenue by Type (2023-2028) & (USD Million)
Table 28. World Radiopharmaceutical Therapy Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Radiopharmaceutical Therapy Revenue by Application (2017-2022) & (USD Million)
Table 30. World Radiopharmaceutical Therapy Revenue by Application (2023-2028) & (USD Million)
Table 31. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 32. Bracco Imaging Major Business
Table 33. Bracco Imaging Radiopharmaceutical Therapy Product and Services
Table 34. Bracco Imaging Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Bracco Imaging Recent Developments/Updates
Table 36. Bracco Imaging Competitive Strengths & Weaknesses
Table 37. Bayer Basic Information, Manufacturing Base and Competitors
Table 38. Bayer Major Business
Table 39. Bayer Radiopharmaceutical Therapy Product and Services
Table 40. Bayer Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Bayer Recent Developments/Updates
Table 42. Bayer Competitive Strengths & Weaknesses
Table 43. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 44. Mallinckrodt Major Business
Table 45. Mallinckrodt Radiopharmaceutical Therapy Product and Services
Table 46. Mallinckrodt Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Mallinckrodt Recent Developments/Updates
Table 48. Mallinckrodt Competitive Strengths & Weaknesses
Table 49. Nordion Basic Information, Manufacturing Base and Competitors
Table 50. Nordion Major Business
Table 51. Nordion Radiopharmaceutical Therapy Product and Services
Table 52. Nordion Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Nordion Recent Developments/Updates
Table 54. Nordion Competitive Strengths & Weaknesses
Table 55. Triad Isotopes Basic Information, Manufacturing Base and Competitors
Table 56. Triad Isotopes Major Business
Table 57. Triad Isotopes Radiopharmaceutical Therapy Product and Services
Table 58. Triad Isotopes Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Triad Isotopes Recent Developments/Updates
Table 60. Triad Isotopes Competitive Strengths & Weaknesses
Table 61. Lantheus Basic Information, Manufacturing Base and Competitors
Table 62. Lantheus Major Business
Table 63. Lantheus Radiopharmaceutical Therapy Product and Services
Table 64. Lantheus Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Lantheus Recent Developments/Updates
Table 66. Lantheus Competitive Strengths & Weaknesses
Table 67. IBA Group Basic Information, Manufacturing Base and Competitors
Table 68. IBA Group Major Business
Table 69. IBA Group Radiopharmaceutical Therapy Product and Services
Table 70. IBA Group Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. IBA Group Recent Developments/Updates
Table 72. IBA Group Competitive Strengths & Weaknesses
Table 73. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 74. GE Healthcare Major Business
Table 75. GE Healthcare Radiopharmaceutical Therapy Product and Services
Table 76. GE Healthcare Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. GE Healthcare Recent Developments/Updates
Table 78. GE Healthcare Competitive Strengths & Weaknesses
Table 79. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 80. China Isotope & Radiation Major Business
Table 81. China Isotope & Radiation Radiopharmaceutical Therapy Product and Services
Table 82. China Isotope & Radiation Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. China Isotope & Radiation Recent Developments/Updates
Table 84. China Isotope & Radiation Competitive Strengths & Weaknesses
Table 85. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Jubilant Pharma Major Business
Table 87. Jubilant Pharma Radiopharmaceutical Therapy Product and Services
Table 88. Jubilant Pharma Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Jubilant Pharma Recent Developments/Updates
Table 90. Jubilant Pharma Competitive Strengths & Weaknesses
Table 91. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 92. Eli Lilly Major Business
Table 93. Eli Lilly Radiopharmaceutical Therapy Product and Services
Table 94. Eli Lilly Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Eli Lilly Recent Developments/Updates
Table 96. Eli Lilly Competitive Strengths & Weaknesses
Table 97. Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table 98. Advanced Accelerator Applications Major Business
Table 99. Advanced Accelerator Applications Radiopharmaceutical Therapy Product and Services
Table 100. Advanced Accelerator Applications Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Advanced Accelerator Applications Recent Developments/Updates
Table 102. Advanced Accelerator Applications Competitive Strengths & Weaknesses
Table 103. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 104. SIEMENS Major Business
Table 105. SIEMENS Radiopharmaceutical Therapy Product and Services
Table 106. SIEMENS Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. SIEMENS Recent Developments/Updates
Table 108. SIEMENS Competitive Strengths & Weaknesses
Table 109. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 110. Dongcheng Major Business
Table 111. Dongcheng Radiopharmaceutical Therapy Product and Services
Table 112. Dongcheng Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Dongcheng Recent Developments/Updates
Table 114. Navidea Basic Information, Manufacturing Base and Competitors
Table 115. Navidea Major Business
Table 116. Navidea Radiopharmaceutical Therapy Product and Services
Table 117. Navidea Radiopharmaceutical Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 118. Radiopharmaceutical Therapy Raw Material
Table 119. Key Manufacturers of Radiopharmaceutical Therapy Raw Materials
Table 120. Radiopharmaceutical Therapy Typical Distributors
Table 121. Radiopharmaceutical Therapy Typical Customers
LIST OF FIGURES
Figure 1. Radiopharmaceutical Therapy Picture
Figure 2. World Radiopharmaceutical Therapy Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Radiopharmaceutical Therapy Total Market Size (2017-2028) & (USD Million)
Figure 4. World Radiopharmaceutical Therapy Market Size Market Share by Region (2017-2028)
Figure 5. United States Radiopharmaceutical Therapy Market Size (2017-2028) & (USD Million)
Figure 6. China Radiopharmaceutical Therapy Market Size (2017-2028) & (USD Million)
Figure 7. Europe Radiopharmaceutical Therapy Market Size (2017-2028) & (USD Million)
Figure 8. Japan Radiopharmaceutical Therapy Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Radiopharmaceutical Therapy Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Radiopharmaceutical Therapy Market Size (2017-2028) & (USD Million)
Figure 11. India Radiopharmaceutical Therapy Market Size (2017-2028) & (USD Million)
Figure 12. Radiopharmaceutical Therapy Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Radiopharmaceutical Therapy by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Radiopharmaceutical Therapy Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Radiopharmaceutical Therapy Markets in 2021
Figure 17. United States VS China: Radiopharmaceutical Therapy Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Radiopharmaceutical Therapy Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Radiopharmaceutical Therapy Market Size Market Share by Type in 2021
Figure 20. Actinium-225
Figure 21. Lutetium-177
Figure 22. Radium-223
Figure 23. Holmium-166
Figure 24. Other
Figure 25. World Radiopharmaceutical Therapy Market Size Market Share by Type (2017-2028)
Figure 26. World Radiopharmaceutical Therapy Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 27. World Radiopharmaceutical Therapy Market Size Market Share by Application in 2021
Figure 28. Oncology
Figure 29. Cardiology
Figure 30. Other
Figure 31. World Radiopharmaceutical Therapy Market Size Market Share by Application (2017-2028)
Figure 32. Manufacturing Cost Structure Analysis of Radiopharmaceutical Therapy in 2021
Figure 33. Manufacturing Process Analysis of Radiopharmaceutical Therapy
Figure 34. Radiopharmaceutical Therapy Industrial Chain
Figure 35. Distribution Channel Breakdown for Radiopharmaceutical Therapy Shipments (%): 2017-2028
Figure 36. Direct Channel Pros & Cons
Figure 37. Indirect Channel Pros & Cons
Figure 38. Methodology
Figure 39. Research Process and Data Source
Figure 1. Radiopharmaceutical Therapy Picture
Figure 2. World Radiopharmaceutical Therapy Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Radiopharmaceutical Therapy Total Market Size (2017-2028) & (USD Million)
Figure 4. World Radiopharmaceutical Therapy Market Size Market Share by Region (2017-2028)
Figure 5. United States Radiopharmaceutical Therapy Market Size (2017-2028) & (USD Million)
Figure 6. China Radiopharmaceutical Therapy Market Size (2017-2028) & (USD Million)
Figure 7. Europe Radiopharmaceutical Therapy Market Size (2017-2028) & (USD Million)
Figure 8. Japan Radiopharmaceutical Therapy Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Radiopharmaceutical Therapy Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Radiopharmaceutical Therapy Market Size (2017-2028) & (USD Million)
Figure 11. India Radiopharmaceutical Therapy Market Size (2017-2028) & (USD Million)
Figure 12. Radiopharmaceutical Therapy Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Radiopharmaceutical Therapy by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Radiopharmaceutical Therapy Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Radiopharmaceutical Therapy Markets in 2021
Figure 17. United States VS China: Radiopharmaceutical Therapy Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Radiopharmaceutical Therapy Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Radiopharmaceutical Therapy Market Size Market Share by Type in 2021
Figure 20. Actinium-225
Figure 21. Lutetium-177
Figure 22. Radium-223
Figure 23. Holmium-166
Figure 24. Other
Figure 25. World Radiopharmaceutical Therapy Market Size Market Share by Type (2017-2028)
Figure 26. World Radiopharmaceutical Therapy Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 27. World Radiopharmaceutical Therapy Market Size Market Share by Application in 2021
Figure 28. Oncology
Figure 29. Cardiology
Figure 30. Other
Figure 31. World Radiopharmaceutical Therapy Market Size Market Share by Application (2017-2028)
Figure 32. Manufacturing Cost Structure Analysis of Radiopharmaceutical Therapy in 2021
Figure 33. Manufacturing Process Analysis of Radiopharmaceutical Therapy
Figure 34. Radiopharmaceutical Therapy Industrial Chain
Figure 35. Distribution Channel Breakdown for Radiopharmaceutical Therapy Shipments (%): 2017-2028
Figure 36. Direct Channel Pros & Cons
Figure 37. Indirect Channel Pros & Cons
Figure 38. Methodology
Figure 39. Research Process and Data Source
